Andrew Fischer, OD
Optometrist · Huntingburg, INNPI 1790281905
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (35.1%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Alcon at 26.0% of the total. Reporting peaked in 2021 at $1,619 and has fallen 97.9% since, to $35 in 2025.
Across 32 payments — averaging $73.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$611
- Coopervision Inc.$548
- Johnson & Johnson Vision Care, Inc.$530
- Bausch & Lomb Americas Inc.$204
- Tarsus Pharmaceuticals, Inc.$150
- Rxsight Inc$70
- plus $237 from 7 others
What the payments were for
- Consulting fees$37516%
- Speaking & faculty fees$75032%
- Travel & lodging$40017%
- Food & beverage$82435%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AIR OPTIX$508
- Acuvue$508
- Clariti Contact Lens$375
- XIIDRA$113
- MIEBO$113
How this compares
$2,350 in reported general payments places this provider in the 80th percentile of 1,318 optometrist providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 13 | $12,044 |
| LumiganBimatoprost | 17 | $4,088 |
| Timolol Maleate | 35 | $1,298 |
| Latanoprost | 47 | $248 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Huntingburg
- Damon DierkerIndianapolis$707K
- Jason JedlickaBloomington$456K
- Kari RiinaFishers$308K
- Rhonda RobinsonIndianapolis$205K
- John CzajaMerrillville$189K
- Peter KollbaumBloomington$60K
- Ryan GustusBluffton$48K
- Steve VargoHighland$48K
- Helen TzanetakosMunster$47K
- Nicholas McColleyGreenfield$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.